Align Technology Reports Strong Q4 Earnings Beat
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 05 2026
0mins
Should l Buy ALGN?
Source: Benzinga
- Earnings Beat: Align Technology reported Q4 earnings of $3.29 per share, surpassing analyst expectations of $2.97, indicating a significant improvement in profitability and boosting market confidence in future growth.
- Sales Growth: The company achieved quarterly sales of $1.047 billion, exceeding the consensus estimate of $1.033 billion, demonstrating robust performance amid strong market demand.
- Stock Surge: Align's shares jumped 10.4% in pre-market trading to $178.13, reflecting a positive investor reaction to the financial results, which may attract more investor interest.
- Increased Market Confidence: This earnings beat not only enhances Align's market image but also potentially supports its future investment and expansion plans, further solidifying its leadership position in the industry.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALGN?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALGN
Wall Street analysts forecast ALGN stock price to rise
13 Analyst Rating
8 Buy
4 Hold
1 Sell
Moderate Buy
Current: 178.400
Low
169.00
Averages
198.70
High
220.00
Current: 178.400
Low
169.00
Averages
198.70
High
220.00
About ALGN
Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Align Technology Reports Strong Q1 2026 Earnings with Record Clear Aligner Shipments
- Strong Performance: Align Technology reported total revenues of $1.041 billion for Q1 2026, with an overall gross margin of 70.8%, reflecting a 1.4 percentage point year-over-year increase, indicating robust market performance and improved profitability.
- Record Clear Aligner Shipments: The company achieved a record shipment of 686,000 Clear Aligners in Q1, with 449,000 adults and 237,000 teens and kids treated, demonstrating sustained strong demand in the global market.
- Cautious Future Outlook: Align expects Q2 2026 worldwide revenues to range from $1.04 billion to $1.06 billion, while acknowledging potential impacts from ongoing military actions in the Middle East, yet maintaining a full-year revenue growth forecast of 3% to 4%.
- Stock Buyback Plan: The company announced plans to repurchase up to an additional $200 million of its common stock starting around May 1, 2026, reflecting confidence in its stock value and providing additional returns to shareholders.
See More
Align (ALGN) Q1 2026 Earnings Call Transcript
See More
Align Technology Set to Announce Q1 Earnings on April 29
- Earnings Announcement: Align Technology (ALGN) is set to release its Q1 2023 earnings report on April 29 after market close, with consensus EPS estimated at $2.29, reflecting a 7.5% year-over-year increase, which could directly impact the stock price.
- Revenue Expectations: The revenue forecast for Q1 stands at $1.02 billion, representing a 4.2% year-over-year growth, and achieving this target would further solidify the company's position in the market, particularly regarding its international growth potential.
- Historical Performance Review: Over the past two years, ALGN has exceeded EPS estimates 75% of the time and revenue estimates 50% of the time, indicating a level of stability in profitability that may bolster investor confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 2 upward revisions and 8 downward adjustments, while revenue estimates experienced 6 upward revisions and 1 downward adjustment, reflecting varying market perceptions regarding the company's future performance.
See More
U.S. Stocks Near All-Time Highs as Investors Eye Tech Giants' Earnings
- Strong Market Performance: The S&P 500 and Nasdaq Composite indices reached new all-time highs in April, rising over 8% and 13% respectively, indicating robust market resilience despite ongoing geopolitical tensions and AI disruption concerns, reflecting investor confidence in tech stocks.
- Earnings Pressure on Tech Giants: Next week, five of the 'Magnificent Seven' companies will report earnings, with market expectations for them to demonstrate sufficient revenue growth to justify their high AI expenditures; Alphabet, Amazon, Meta, and Microsoft have all seen stock price increases of over 10% this month, highlighting the market's keen interest in their performance.
- Federal Reserve Meeting Impact: This is expected to be Jerome Powell's last meeting as chair, with the market widely anticipating that the Fed will keep interest rates unchanged, although rising oil prices could complicate future monetary policy, necessitating close attention to how this dynamic may affect the market.
- Cautious Investor Sentiment: As the traditional market adage 'Sell in May' approaches, investors remain wary of potential downside risks, particularly in light of poor software stock performance and rising oil prices, which could further dampen market sentiment.
See More
Align Technology Recognized as a Top 100 Global Innovator for Five Consecutive Years
- Global Innovator Recognition: Align Technology has been named a Top 100 Global Innovator for the fifth consecutive year in the 2026 LexisNexis Innovation Momentum report, highlighting its leadership and innovation capabilities in digital dentistry, thereby reinforcing its competitive advantage in the market.
- Patent Portfolio Growth: With over 3,000 active patents, Align's ongoing investments in key innovation areas such as AI-driven treatment planning, 3D printing advancements, and digital diagnostics enhance product functionality and design flexibility, solidifying its market position.
- Strong Technology Pipeline: Align's evolving technology pipeline aims to enhance treatment experiences through AI technologies, positively impacting both doctors and patients while expanding opportunities in the global $600 billion consumer market.
- Increased Industry Influence: The LexisNexis evaluation, based on an analysis of over 17 million global patents, underscores Align's continuous innovation, which not only boosts its industry influence but also lays the groundwork for future technological and industrial advancements.
See More
Align Technology Recognized as Top Global Innovator for Fifth Consecutive Year
- Global Innovator Recognition: Align Technology has been recognized as a Top 100 Global Innovator for the fifth consecutive year in the 2026 LexisNexis Innovation Momentum report, highlighting its leadership and ongoing investment in digital dentistry innovation.
- Growing Patent Portfolio: With over 3,000 active patents, Align's portfolio reflects significant R&D investments in key areas such as AI-driven treatment planning, 3D printing innovations, and digital diagnostics, further solidifying its competitive edge in the market.
- Strong Technology Pipeline: Align's evolving technology pipeline focuses on enhancing patient experiences through AI-driven diagnostic tools and real-time treatment planning, positioning the company at the forefront of the future of digital dentistry.
- Vast Market Opportunities: Align's technology solutions serve approximately 295,600 doctor customers and tap into a global consumer market of 600 million, having treated over 22.1 million patients, showcasing its immense potential in the digital dentistry sector.
See More
Align Technology Reports Strong Q1 2026 Earnings with Record Clear Aligner Shipments
- Strong Performance: Align Technology reported total revenues of $1.041 billion for Q1 2026, with an overall gross margin of 70.8%, reflecting a 1.4 percentage point year-over-year increase, indicating robust market performance and improved profitability.
- Record Clear Aligner Shipments: The company achieved a record shipment of 686,000 Clear Aligners in Q1, with 449,000 adults and 237,000 teens and kids treated, demonstrating sustained strong demand in the global market.
- Cautious Future Outlook: Align expects Q2 2026 worldwide revenues to range from $1.04 billion to $1.06 billion, while acknowledging potential impacts from ongoing military actions in the Middle East, yet maintaining a full-year revenue growth forecast of 3% to 4%.
- Stock Buyback Plan: The company announced plans to repurchase up to an additional $200 million of its common stock starting around May 1, 2026, reflecting confidence in its stock value and providing additional returns to shareholders.
See More
Align (ALGN) Q1 2026 Earnings Call Transcript
See More
Align Technology Set to Announce Q1 Earnings on April 29
- Earnings Announcement: Align Technology (ALGN) is set to release its Q1 2023 earnings report on April 29 after market close, with consensus EPS estimated at $2.29, reflecting a 7.5% year-over-year increase, which could directly impact the stock price.
- Revenue Expectations: The revenue forecast for Q1 stands at $1.02 billion, representing a 4.2% year-over-year growth, and achieving this target would further solidify the company's position in the market, particularly regarding its international growth potential.
- Historical Performance Review: Over the past two years, ALGN has exceeded EPS estimates 75% of the time and revenue estimates 50% of the time, indicating a level of stability in profitability that may bolster investor confidence.
- Estimate Revision Dynamics: In the last three months, EPS estimates have seen 2 upward revisions and 8 downward adjustments, while revenue estimates experienced 6 upward revisions and 1 downward adjustment, reflecting varying market perceptions regarding the company's future performance.
See More
U.S. Stocks Near All-Time Highs as Investors Eye Tech Giants' Earnings
- Strong Market Performance: The S&P 500 and Nasdaq Composite indices reached new all-time highs in April, rising over 8% and 13% respectively, indicating robust market resilience despite ongoing geopolitical tensions and AI disruption concerns, reflecting investor confidence in tech stocks.
- Earnings Pressure on Tech Giants: Next week, five of the 'Magnificent Seven' companies will report earnings, with market expectations for them to demonstrate sufficient revenue growth to justify their high AI expenditures; Alphabet, Amazon, Meta, and Microsoft have all seen stock price increases of over 10% this month, highlighting the market's keen interest in their performance.
- Federal Reserve Meeting Impact: This is expected to be Jerome Powell's last meeting as chair, with the market widely anticipating that the Fed will keep interest rates unchanged, although rising oil prices could complicate future monetary policy, necessitating close attention to how this dynamic may affect the market.
- Cautious Investor Sentiment: As the traditional market adage 'Sell in May' approaches, investors remain wary of potential downside risks, particularly in light of poor software stock performance and rising oil prices, which could further dampen market sentiment.
See More
Align Technology Recognized as a Top 100 Global Innovator for Five Consecutive Years
- Global Innovator Recognition: Align Technology has been named a Top 100 Global Innovator for the fifth consecutive year in the 2026 LexisNexis Innovation Momentum report, highlighting its leadership and innovation capabilities in digital dentistry, thereby reinforcing its competitive advantage in the market.
- Patent Portfolio Growth: With over 3,000 active patents, Align's ongoing investments in key innovation areas such as AI-driven treatment planning, 3D printing advancements, and digital diagnostics enhance product functionality and design flexibility, solidifying its market position.
- Strong Technology Pipeline: Align's evolving technology pipeline aims to enhance treatment experiences through AI technologies, positively impacting both doctors and patients while expanding opportunities in the global $600 billion consumer market.
- Increased Industry Influence: The LexisNexis evaluation, based on an analysis of over 17 million global patents, underscores Align's continuous innovation, which not only boosts its industry influence but also lays the groundwork for future technological and industrial advancements.
See More
Align Technology Recognized as Top Global Innovator for Fifth Consecutive Year
- Global Innovator Recognition: Align Technology has been recognized as a Top 100 Global Innovator for the fifth consecutive year in the 2026 LexisNexis Innovation Momentum report, highlighting its leadership and ongoing investment in digital dentistry innovation.
- Growing Patent Portfolio: With over 3,000 active patents, Align's portfolio reflects significant R&D investments in key areas such as AI-driven treatment planning, 3D printing innovations, and digital diagnostics, further solidifying its competitive edge in the market.
- Strong Technology Pipeline: Align's evolving technology pipeline focuses on enhancing patient experiences through AI-driven diagnostic tools and real-time treatment planning, positioning the company at the forefront of the future of digital dentistry.
- Vast Market Opportunities: Align's technology solutions serve approximately 295,600 doctor customers and tap into a global consumer market of 600 million, having treated over 22.1 million patients, showcasing its immense potential in the digital dentistry sector.
See More
